| Unique ID issued by UMIN | UMIN000021418 |
|---|---|
| Receipt number | R000024674 |
| Scientific Title | The effective of the triple therapy for clarithromycin-resistant Helicobacter pylori using Vonoprazan,AMPC,MNZ. |
| Date of disclosure of the study information | 2016/03/10 |
| Last modified on | 2017/02/03 16:50:25 |
The effective of the triple therapy for clarithromycin-resistant Helicobacter pylori using Vonoprazan,AMPC,MNZ.
Eradication therapy for CAM-resistant Helicobacter pylori.
The effective of the triple therapy for clarithromycin-resistant Helicobacter pylori using Vonoprazan,AMPC,MNZ.
Eradication therapy for CAM-resistant Helicobacter pylori.
| Japan |
Helicobacter pylori infection
| Gastroenterology |
Others
NO
Varify the effecacy of first line triple therapy for the clarithromycin-resistant Helicobacter pylori using vonoprazan, amoxicillin and metronidazole.
Efficacy
eradication rate
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Helicobacter pylori infected patient
Penicillin allergy
200
| 1st name | |
| Middle name | |
| Last name | Hisatsugu Noda |
Aichi medical university
gastroenterology
1-1 yazakokarimata Nagakute city Aichi
0561-62-3311
bisaipan@aichi-med-u.ac.jp
| 1st name | |
| Middle name | |
| Last name | Hisatsugu Noda |
Aichi medical university
gastroenterology
1-1 yazakokarimata Nagakute city Aichi
0561-62-3311
bisaipan@aichi-med-u.ac.jp
Aichi medical university
Aichi medical university
Self funding
NO
| 2016 | Year | 03 | Month | 10 | Day |
Unpublished
Terminated
| 2016 | Year | 03 | Month | 08 | Day |
| 2016 | Year | 03 | Month | 10 | Day |
Cohort study
All the members who were equal to criteria for selection in the patients who consulted our institution in March, 2019 from April, 2016
| 2016 | Year | 03 | Month | 10 | Day |
| 2017 | Year | 02 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024674